- Home
- VEEE vs RNAZ Comparison
VEEE vs RNAZ Comparison
Compare VEEE & RNAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VEEE
- RNAZ
- Stock Information
- Founded
- VEEE 1994
- RNAZ 2016
- Country
- VEEE United States
- RNAZ United States
- Employees
- VEEE N/A
- RNAZ N/A
- Industry
- VEEE Marine Transportation
- RNAZ Biotechnology: Pharmaceutical Preparations
- Sector
- VEEE Industrials
- RNAZ Health Care
- Exchange
- VEEE Nasdaq
- RNAZ Nasdaq
- Market Cap
- VEEE 5.8M
- RNAZ 6.1M
- IPO Year
- VEEE 2021
- RNAZ 2021
- Fundamental
- Price
- VEEE $1.95
- RNAZ $9.73
- Analyst Decision
- VEEE
- RNAZ Strong Buy
- Analyst Count
- VEEE 0
- RNAZ 1
- Target Price
- VEEE N/A
- RNAZ $280.00
- AVG Volume (30 Days)
- VEEE 106.3K
- RNAZ 17.0K
- Earning Date
- VEEE 08-07-2025
- RNAZ 08-14-2025
- Dividend Yield
- VEEE N/A
- RNAZ N/A
- EPS Growth
- VEEE N/A
- RNAZ N/A
- EPS
- VEEE N/A
- RNAZ N/A
- Revenue
- VEEE $13,153,262.00
- RNAZ N/A
- Revenue This Year
- VEEE N/A
- RNAZ N/A
- Revenue Next Year
- VEEE N/A
- RNAZ N/A
- P/E Ratio
- VEEE N/A
- RNAZ N/A
- Revenue Growth
- VEEE N/A
- RNAZ N/A
- 52 Week Low
- VEEE $1.88
- RNAZ $6.15
- 52 Week High
- VEEE $9.30
- RNAZ $739.20
- Technical
- Relative Strength Index (RSI)
- VEEE 38.85
- RNAZ 45.35
- Support Level
- VEEE $1.98
- RNAZ $9.59
- Resistance Level
- VEEE $2.10
- RNAZ $10.48
- Average True Range (ATR)
- VEEE 0.09
- RNAZ 0.73
- MACD
- VEEE -0.01
- RNAZ -0.16
- Stochastic Oscillator
- VEEE 22.17
- RNAZ 17.88
About VEEE Twin Vee PowerCats Co.
Twin Vee PowerCats Co is a designer, manufacturer, and marketer of recreational and commercial power boats to use for fishing, diving and water skiing, and commercial activities including transportation, eco-tours, fishing, and diving expeditions. The company offers various boat models, including Twin Vee 400 GFX2 CC, Twin Vee 280 GFX2 CC, and Twin Vee 260 Center Console STX, among others. Its products are marketed under two brands, Twin Vee for its catamarans, or dual-hull vessels, and Aquasport for its V-hull boats. The company sells its boats through a network of independent boat dealers across North America, the Caribbean, and Central America who resell the boats to the end user, Twin Vee customers.
About RNAZ TransCode Therapeutics Inc.
TransCode Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing innovative drugs and diagnostics for treating and identifying cancer. TransCode recently commenced its first clinical trial. The Company's lead therapeutic candidate, TTX-MC138, comprises an oligonucleotide conjugated to an iron oxide nanoparticle designed to be administered by infusion to inhibit the ability of metastatic tumor cells to survive. The goal of the therapy, if approved, is to achieve durable disease regression and long-term patient survival.